These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 27181836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY, Shah DA, Dave RH.
    Int J Pharm; 2019 Mar 25; 559():348-359. PubMed ID: 30721724
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of improved oral bioavailability of ritonavir nanosuspension.
    Karakucuk A, Teksin ZS, Eroglu H, Celebi N.
    Eur J Pharm Sci; 2019 Apr 01; 131():153-158. PubMed ID: 30790704
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C, Dang Y, Lin G, Yao Y, Li G, Ji G, Shen H, Xie Y.
    Int J Pharm; 2014 Dec 30; 477(1-2):251-60. PubMed ID: 25445518
    [Abstract] [Full Text] [Related]

  • 8. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ, Gajera BY, Dave RH.
    Drug Dev Ind Pharm; 2018 Dec 30; 44(12):1942-1952. PubMed ID: 30027778
    [Abstract] [Full Text] [Related]

  • 9. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
    Qiao F, Zhao Y, Mai Y, Guo J, Dong L, Zhang W, Yang J.
    Planta Med; 2020 May 30; 86(8):538-547. PubMed ID: 32294789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
    Du B, Li XT, Zhao Y, A YM, Zhang ZZ.
    Pharmazie; 2010 Jul 30; 65(7):471-6. PubMed ID: 20662313
    [Abstract] [Full Text] [Related]

  • 14. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS, Elnaggar YS, Abdallah OY.
    Int J Pharm; 2013 Sep 15; 454(1):462-71. PubMed ID: 23830765
    [Abstract] [Full Text] [Related]

  • 15. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
    Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, Tang X, Pan W, Han J, He Z.
    Int J Pharm; 2009 Sep 08; 379(1):167-73. PubMed ID: 19505545
    [Abstract] [Full Text] [Related]

  • 16. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
    Marzan AL, Tabassum R, Jahan B, Asif MH, Reza HM, Kazi M, Alshehri SM, de Matas M, Shariare MH.
    Curr Drug Deliv; 2018 Sep 08; 15(5):672-685. PubMed ID: 29359667
    [Abstract] [Full Text] [Related]

  • 17. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension.
    Guo JJ, Yue PF, Lv JL, Han J, Fu SS, Jin SX, Jin SY, Yuan HL.
    Int J Pharm; 2013 Jan 30; 441(1-2):227-33. PubMed ID: 23220096
    [Abstract] [Full Text] [Related]

  • 18. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies.
    Tian X, Li H, Zhang D, Liu G, Jia L, Zheng D, Shen J, Shen Y, Zhang Q.
    Colloids Surf B Biointerfaces; 2013 Aug 01; 108():29-33. PubMed ID: 23528604
    [Abstract] [Full Text] [Related]

  • 19. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK, Patel MH, Patel K.
    Drug Dev Ind Pharm; 2016 Aug 01; 42(5):758-68. PubMed ID: 26548349
    [Abstract] [Full Text] [Related]

  • 20. Formulation and Evaluation of Isradipine Nanosuspension and Exploring its Role as a Potential Anticancer Drug by Computational Approach.
    Mohapatra PK, Srivastava R, Varshney KK, Babu SH.
    Anticancer Agents Med Chem; 2022 Aug 01; 22(10):1984-2001. PubMed ID: 34353274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.